Intrafascial dissection significantly increases positive surgical margin and biochemical recurrence rates after robotic-assisted radical prostatectomy

Urol Int. 2012;89(1):17-24. doi: 10.1159/000339254. Epub 2012 Jun 27.

Abstract

Introduction: Improved visualization and magnification in robot-assisted laparoscopic radical prostatectomy (RALRP) has tempted many urologists to dissect the neurovascular bundle closer to the prostate following the layers of the pseudo-capsule of the prostate. This might bear a higher risk of decreased tumor control.

Materials and methods: An analysis of a consecutive series of 186 patients who underwent RALRP at our institution was performed. The outcome of patients with intrafascial nerve-sparing (INS) was compared with the outcome of patients who underwent interfascial, extrafascial or no nerve-sparing (non-INS).

Results: A total of 80 patients (43.0%) received INS. The overall R1 rate was 27.9%. For pT2 tumors the rate of R1 was 33.8% in INS versus 14.8% in non-INS (odds ratio 2.936, 95% confidence interval 1.338-6.443, p = 0.007). Recurrence-free survival was significantly shorter in INS (p = 0.05; hazard ratio 3.791).

Conclusion: The intrafascial dissection technique for RALRP bears a high risk of incomplete resection in localized prostate cancer resulting in unfavorable outcome.

Publication types

  • Comparative Study

MeSH terms

  • Aged
  • Chi-Square Distribution
  • Disease-Free Survival
  • Dissection / adverse effects*
  • Dissection / mortality
  • Humans
  • Kaplan-Meier Estimate
  • Laparoscopy / adverse effects*
  • Laparoscopy / mortality
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Neoplasm Grading
  • Odds Ratio
  • Proportional Hazards Models
  • Prostate-Specific Antigen / blood*
  • Prostatectomy / adverse effects*
  • Prostatectomy / methods
  • Prostatectomy / mortality
  • Prostatic Neoplasms / blood
  • Prostatic Neoplasms / mortality
  • Prostatic Neoplasms / pathology
  • Prostatic Neoplasms / surgery*
  • Retrospective Studies
  • Risk Assessment
  • Risk Factors
  • Robotics*
  • Surgery, Computer-Assisted / adverse effects*
  • Surgery, Computer-Assisted / mortality
  • Schweiz
  • Time Factors
  • Treatment Outcome

Substances

  • Prostate-Specific Antigen